. (2019). Effect of Splenectomy on Blood Picture in Children with Thalassemia Major Ahmed Adel Fathy Mohamed(Assistant Researcher at NRC), Gamal Sami Ali(Professor of pediatrics at FPGS), M. Khaled El-Menabbawy (Professor at NRC), Fatma A. Elzaree(Researcher at NRC), Reham Sabrey Abdel Aal(Lecturer of pediatrics at FPGS).. مجلة دراسات الطفولة, 22(04.2019), 1-8. doi: 10.21608/jsc.2019.45801
. "Effect of Splenectomy on Blood Picture in Children with Thalassemia Major Ahmed Adel Fathy Mohamed(Assistant Researcher at NRC), Gamal Sami Ali(Professor of pediatrics at FPGS), M. Khaled El-Menabbawy (Professor at NRC), Fatma A. Elzaree(Researcher at NRC), Reham Sabrey Abdel Aal(Lecturer of pediatrics at FPGS).". مجلة دراسات الطفولة, 22, 04.2019, 2019, 1-8. doi: 10.21608/jsc.2019.45801
. (2019). 'Effect of Splenectomy on Blood Picture in Children with Thalassemia Major Ahmed Adel Fathy Mohamed(Assistant Researcher at NRC), Gamal Sami Ali(Professor of pediatrics at FPGS), M. Khaled El-Menabbawy (Professor at NRC), Fatma A. Elzaree(Researcher at NRC), Reham Sabrey Abdel Aal(Lecturer of pediatrics at FPGS).', مجلة دراسات الطفولة, 22(04.2019), pp. 1-8. doi: 10.21608/jsc.2019.45801
. Effect of Splenectomy on Blood Picture in Children with Thalassemia Major Ahmed Adel Fathy Mohamed(Assistant Researcher at NRC), Gamal Sami Ali(Professor of pediatrics at FPGS), M. Khaled El-Menabbawy (Professor at NRC), Fatma A. Elzaree(Researcher at NRC), Reham Sabrey Abdel Aal(Lecturer of pediatrics at FPGS).. مجلة دراسات الطفولة, 2019; 22(04.2019): 1-8. doi: 10.21608/jsc.2019.45801
Effect of Splenectomy on Blood Picture in Children with Thalassemia Major Ahmed Adel Fathy Mohamed(Assistant Researcher at NRC), Gamal Sami Ali(Professor of pediatrics at FPGS), M. Khaled El-Menabbawy (Professor at NRC), Fatma A. Elzaree(Researcher at NRC), Reham Sabrey Abdel Aal(Lecturer of pediatrics at FPGS).
Abstract Background: Beta thalassemias are a group of inherited autosomal recessive hematological disorders, it results in red blood cell destruction with symptoms of anemia. Red blood cell destruction, repeated blood transfusion and bad compliance to routine use of iron chelator lead to iron accumulation in the heart, liver and endocrine organs, Clinical picture of this disease is microcytosis and hemolytic anemia that need repeated blood transfusion which may lead to irreversible damage to organs and tissues due to iron accumulation, about 90% of patients with thalassemia had undergone splenectomy by age 15 years with a result in stoppage of transfusion requirement in most thalassemia intermedia patients and with a decrease in the need for red cell transfusions in thalassemia major patients. Aim of study: To study the effect of splenectomy on different blood picture parameters in children with β- Thalassemia Major. Methods: A prospective study that was conducted on 40 confirmed homozygous β- thalassemia major patients before and after splenectomy with complete physical examination was performed for all patients by assessing anthropometric measurements, vital signs, presence of pallor, jaundice, liver status. Complete blood picture with blood indices by Coulter Counter in addition to reticulocytes count. Results: After splenectomy there is higher mean level of hemoglobin with 5.3% increase, higher platelet count with 110% rise in the mean platelet count and higher total leucocytic count with 42.5% increase and decreased reticulocytic count with a drop of 41% in the mean level of reticulocytes with all results statistically highly significant. Conclusion: There is improvement of blood picture parameters after splenectomy which includes increasing of hemoglobin level and platelet count with decreased level of reticulocytic count. The increase of total leucocytic count after splenectomy is explained by the increased rate of infection.
نقاط رئيسية
Thalassemia Major – Blood parameters _ children- Splenectomy.
Effect of Splenectomy on Blood Picture in Children with Thalassemia Major
Ahmed Adel Fathy Mohamed(Assistant Researcher at NRC), Gamal Sami Ali(Professor of pediatrics at FPGS), M. Khaled El-Menabbawy (Professor at NRC), Fatma A. Elzaree(Researcher at NRC), Reham Sabrey Abdel Aal(Lecturer of pediatrics at FPGS).
Abstract
Background: Beta thalassemias are a group of inherited autosomal recessive hematological disorders, it results in red blood cell destruction with symptoms of anemia. Red blood cell destruction, repeated blood transfusion and bad compliance to routine use of iron chelator lead to iron accumulation in the heart, liver and endocrine organs, Clinical picture of this disease is microcytosis and hemolytic anemia that need repeated blood transfusion which may lead to irreversible damage to organs and tissues due to iron accumulation, about 90% of patients with thalassemia had undergone splenectomy by age 15 years with a result in stoppage of transfusion requirement in most thalassemia intermedia patients and with a decrease in the need for red cell transfusions in thalassemia major patients.
Aim of study: To study the effect of splenectomy on different blood picture parameters in children with β- Thalassemia Major.
Methods: A prospective study that was conducted on 40 confirmed homozygous β- thalassemia major patients before and after splenectomy with complete physical examination was performed for all patients by assessing anthropometric measurements, vital signs, presence of pallor, jaundice, liver status. Complete blood picture with blood indices by Coulter Counter in addition to reticulocytes count.
Results: After splenectomy there is higher mean level of hemoglobin with 5.3% increase, higher platelet count with 110% rise in the mean platelet count and higher total leucocytic count with 42.5% increase and decreased reticulocytic count with a drop of 41% in the mean level of reticulocytes with all results statistically highly significant.
Conclusion: There is improvement of blood picture parameters after splenectomy which includes increasing of hemoglobin level and platelet count with decreased level of reticulocytic count. The increase of total leucocytic count after splenectomy is explained by the increased rate of infection.
Key words: Thalassemia Major – Blood parameters _ children- Splenectomy.
تأثیر استئصال الطحال على صورة الدم لدى الأطفال المصابین بأنیمیا البحر الأبیض المتوسط
المستخلص العلمى
الخلفیة العلمیة: أنیمیا البحر الأبیض المتوسط هی مجموعة من الاضطرابات الوراثیة الجسمیة بسبب عیوب فی تخلیق سلاسل الهیموجلوبین ، ینتج عنها تدمیر خلایا الدم الحمراء مع أعراض فقر الدم , وعملیات نقل الدم المتکررة والامتثال السیئ للاستخدام الروتینی للأدویة الطاردة للحدید إلى تراکم الحدید فی القلب والکبد وأجهزة الغدد الصماء . و فى حوالی 90٪ من مرضى الثلاسیمیة یخضعوا لعملیة استئصال الطحال عند بلوغهم عمر 15 سنة مما یؤدى إلى توقف متطلبات نقل الدم فی معظم مرضى الثلاسیمیا الوسطیة مع انخفاض الحاجة إلى نقل خلایا الدم الحمراء فی مرضى الثلاسیمیا الکبرى.
الهدف من البحث: دراسة تأثیر استئصال الطحال على عناصر صورة الدم المختلفة لدى الأطفال المصابین بأنیمیا البحر الأبیض المتوسط .
المرضى واجراءات البحث: تم إجراء دراسة استطلاعیة أجریت على 40 مریض مصابا بأنیمیا البحر الأبیض المتوسط بعد تأکید التشخیص وتماثل الجینات المرضیة قبل وبعد استئصال الطحال. وتم عمل صورة الدم الکاملة مع مؤشرات الدم بواسطه الفحوصات وأجهزة التحلیل المعملى بالإضافة إلى عدد الخلایا الشبکیة.
النتائج: بعد استئصال الطحال هناک مستوى أعلى من الهیموجلوبین مع زیادة بنسبة 5.3٪ وارتفاع فی عدد الصفائح الدمویة بنسبة 110٪ فی متوسط عدد الصفائح الدمویة وزیادة عدد کریات الدم البیضاء مع زیادة 42.5٪ وانخفاض عدد الخلایا الشبکیة مع انخفاض بنسبة 41٪ فی المتوسط مستوى الخلایا الشبکیة وجمیع النتائج ذات دلالات احصائیه عالیه.
التوصیات:- لوحظ من خلال الدراسة زیادة فی عدد کرات الدم البیضاء الکلی بعد استئصال الطحال ووجود خطورة بالاصابه بالعدوى وذلک فینصح باخذ التطعیمات اللازمة قبل استئصال الطحال و الأخذ بسبل الحمایه من العدوى.
الخلاصة:- یوجد تحسن بمعظم عناصر صورة الدم وتشمل زیادة مستوى الهیموجلوبین وعدد الصفائح الدمویة مع انخفاض مستوى عدد الخلایا الشبکی و هناک زیادة فی عدد کریات الدم البیضاء الکلی بعد استئصال الطحال ویمکن تفسیر ذلک من خلال زیادة خطر الأصابه بالعدوى .
الکلمات الدالة: أنیمیا البحر الأبیض المتوسط – عناصر صورة الدم - الأطفال - استئصال الطحال.
Introduction
Beta thalassemias are a group of inherited autosomal recessive hematological disorders spread in the Mediterranean region due to defects in synthesis of β chains of hemoglobin, caused by mutation in the HBB gene on chromosome 11 causing asymptomatic to clinically severe hypochromic microcytic anemia (Hayder and Ali, 2017).
Beta thalassemia major is a hereditary synthesis defect in beta chains of hemoglobin; it results in red blood cell destruction with symptoms of anemia. Red blood cell destruction, repeated blood transfusion and bad compliance to routine use of iron chelator lead to iron accumulation in the heart, liver and endocrine organs (Shodikin et al., 2016).
Beta thalassemia major present in various shapes depending on the beta globin chains defect. The most severe form is beta thalassemia major which happens as a conclusion of inheritance of two beta globin chain mutations either in homozygous or compound heterozygous states. Patients with beta thalassemia major require recurrent blood transfusions for survival due to severe anemia. Clinical picture of this disease is microcytosis and hemolytic anemia that need repeated blood transfusion which may lead to irreversible damage to organs and tissues due to iron accumulation (Tolba et al., 2015).
Splenomegaly in patients with thalassemia major is often huge and mainly associated with severe transfusion dependent anemia due to ineffective erythropoiesis and prolonged hemolysis due to RBC membrane affection associated with precipitation of unbound α globin chains., about 90% of patients with thalassemia had undergone splenectomy by age 15 years with a result in stoppage of transfusion requirement in most thalassemia intermedia patients and with a decrease in the need for red cell transfusions in thalassemia major patients. However, these improvements came at the expense of various splenectomy associated complications including sepsis from encapsulated organisms (although this risk has been overcome with new protein conjugate vaccines and antibiotic prophylaxis) (Neal et al., 2013)
.
Aim of study
To study the effect of splenectomy on different blood picture parameters in children with β- Thalassemia Major.
Patients and methods
This prospective study was conducted on 40 children (males and females) between 6- 18 years of age with confirmed homozygous β- thalassemia major diagnosis recruited from Hematology Clinic, Childrens university hospitals; Ain Shams and Cairo Universities, Egypt, from December 2016 till December 2017, before and after splenectomy done to those patients. Informed consent was taken from all patients or their legal guardians. excluded patients with acute febrile illness within 72 hours prior to enrollment, serious concurrent illness, chronic renal failure and other hematologic disease comorbidity. Data were collected by reviewing medical records as well as by direct patient interviewing. Thorough history taking was obtained including age, sex, consanguinity, other affected siblings, similar family condition, history of disease related complications e.g. transfusion-related infections, allow sensitization, iron-overload, related cardiac, endocrine and liver disturbances etc, history of concomitant medical conditions e.g. viral hepatitis (HBV, HCV), blood transfusion history including age of onset, duration and frequency of transfusion and history of drug therapy e.g. hydroxyurea, chelation. A complete physical examination was performed for all patients by assessing anthropometric measurements, vital signs, presence of pallor, jaundice, liver status. Complete blood picture with blood indices by Coulter Counter in addition to reticulocytes count. Patients' data were analyzed using SPSS 17.0 for windows 7. Quantitative variables were expressed by mean and SD (Standard deviation), compared using unpaired t-student test and Mann-Whitney test. Spearman rank order test was used for correlating quantitative variables. P value was considered to be significant if less than 0.05.
Results
Table (1) Distribution of gender and age of studied patients
N=40
No
%
Gender
Male
Female
29
11
72.5
27.5
Age
Less than 10
10-
15>
5
14
21
12.5
35.0
52.5
Mean SD
Range
Age (years)
13.8 3.0
7.0-17.0
This table shows that 72.5% of the studied patients are male and 27.5% are female with 12.5% of the patients are less than 10 years, 35% of the patients in the age range of 10 to less than 15 and 52.5% of the patients are 15 and above.
Table (2) Comparison between the mean level of blood picture parameters before and after splenectomy among studied patients
N=40
Before
Mean SD
After
Mean SD
Paired t
P
Hemoglobin
7.5 0.3
7.9 0.3
13.8
0.000**
WBCs
8.7 2.7
12.4 2.3
11.5
0.000**
Platelets
203.5 56.1
427.6 90.5
20.4
0.000**
Reticulocytes
8.7 3.0
5.1 2.3
15.1
0.000**
** P
There is higher mean hemoglobin after splenectomy compared to presplenectomy level and the difference is statistically highly significant with 5.3% increase. There is a higher means increases in the mean WBCs 12.4 compared to 8.7 before surgery and the difference is statistically highly significant with 42.5% increase. This table shows higher mean platelets after surgery 427.6 compared to 203.5 before surgery with 110% rise in the mean platelet count and the difference is statistically highly significant. There is a lower mean reticulocytic count after splenectomy compared to pre-surgery level with a drop of 41% in the mean level of reticulocytes and the difference is statistically highly significant.
Discussion
Forty patients 29 (72.5%) males and 11 (27.5%) females were included in our study. All were children aged 6 to 18 years with 12.5% of the patients are less than 10 years, 35% of the patients in the age range of 10 to less than 15 and 52.5% of the patients are 15 and above all with
established diagnosis of β- Thalassemia Major, the previous studies were done on adults (Darzi et al., 2014). To our knowledge, our study was the first to discuss the influence of splenectomy on different blood picture parameters in children with β- Thalassemia Major.
Regarding blood characteristics, the hemoglobin level is below the normal physiological level in all children with β- Thalassemia Major before and after splenectomy it is probably due to the fact that these patients are subjected to a state of chronic anemia that is caused by frequent hemolysis. On the other hand, there is higher mean hemoglobin after splenectomy was 7.9 g/dl compared to presplenectomy level 7.5 g/dl and the difference is statistically highly significant with 5.3% increase which agrees with previous studies (Ammar et al., 2014).
In our study there is higher mean platelets after surgery 427.6 compared to 203.5 before surgery with 110% rise in the mean platelet count and the difference is statistically highly significant and There is a higher mean increases in the mean WBCs 12.4 compared to 8.7 before surgery and the difference is statistically highly significant with 42.5% increase this may be explained by the fact that the spleen is the organ removing aging or abnormal RBC, foreign invaders, and other cells including platelets, WBCs from the circulation. Splenectomy raises circulating platelets and WBC, which may contribute to a high risk of thrombosis and certain infections including meningitis, pneumonia and sepsis which agrees with previous studies (Ruchaneekorn et al., 2013, Cappellini., 2007 and Vento et al., 2006).
It was reported in our study that there is a lower mean reticulocytic count after splenectomy compared to presplenectomy level with a drop of 41% in the mean level of reticulocytes and the difference is statistically highly significant, suggesting the role of spleen in reticulocyte pooling which comes in agreement with previous studies done by Ruchaneekorn et al., 2013 and Khuhapinant et al., 1994.
Conclusion
Ther is an improvement of blood picture parameters includes increasing of hemoglobin level and platelet count with decreased the level of reticulocytic count. There is increase of total leucocytic count after splenectomy with the increased risk of sepsis and infection after splenectomy with the necessity of presplenectomy vaccination.
Recommendation
we noticed that there was increase of total leucocytic count after splenectomy with the increased risk of sepsis and infection after splenectomy with the necessity of presplenectomy vaccination and to perform the ways of prevention of infection with early treatment of infection post splenectomy.
References
Al-Kuraishy HM and Al-Gareeb AI (2017): Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion‑dependent β‑thalassemia. Asian Journal of Transfusion Science, Vol. 11, Issue 1.
Ammar SA, Elsayh KI, Zahran AM and Embaby M (2017): Splenectomy for patients with β- thalassemia major: long-term outcomes. The Egyptian Journal of Surgery; 33:232236.
Cappellini M D (2007): Coagulation in the pathophysiology of hemolytic anemias. Hematology/the Education Program of the American Society of Hematolog, pp. 7478.
Darzi AA, Khakzad M, Kamali S (2014): Influence of splenectomy on immunoglobulins and complement components in major thalassemia. Caspian J Intern Med ; 6(1): 30-33.
Khuhapinant A, Bunyaratvej A, Tatsumi N, Pribwai M and Fucharoen S (1994): Number and maturation of reticulocytes in various genotypes of thalassemia as assessed by flow cytometry. Acta Haematologica, vol. 91, no. 3, pp. 119125.
Neal J, Weinreb, Barry E and Rosenbloom (2013): Splenomegaly, hypersplenism, and hereditary disorders with splenomegaly. Open Journal of Genetics 3: 24-43.
Ruchaneekorn W. Kalpravidh, Thongchai Tangjaidee, Suneerat Hatairaktham, Ratiya Charoensakdi, Narumol Panichkul, Noppadol Siritanaratkul and Suthat Fucharoen (2013): Glutathione Redox System in -Thalassemia/Hb E Patients. The Scientific World Journal Volume 2013, Article ID 543973, 7 pages.
Shodikin M A, Suwarniaty R and Nugroho S (2016): Correlation between Serum ferritin and Cardiac troponin I in major beta thalassemia Children, the journal of tropical life science, VOL. 6, NO. 1, pp. 10-14.
Tolba M R, Soliman N A, El- kamah G Y and EL-shehaby A I (2015): Oxidative Stress Parameters in Beta-Thalassemia. International Journal of Life Sciences Research, Vol. 3, Issue 4.
Vento S, Cainelli F, and Cesario F (2006): Infections and thalassemia. Lancet Infectious Diseases, vol. 6, no. 4, pp. 226–233.
المراجع
Al-Kuraishy HM and Al-Gareeb AI (2017): Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion‑dependent β‑thalassemia. Asian Journal of Transfusion Science, Vol. 11, Issue 1.
Ammar SA, Elsayh KI, Zahran AM and Embaby M (2017): Splenectomy for patients with β- thalassemia major: long-term outcomes. The Egyptian Journal of Surgery; 33:232236.
Cappellini M D (2007): Coagulation in the pathophysiology of hemolytic anemias. Hematology/the Education Program of the American Society of Hematolog, pp. 7478.
Darzi AA, Khakzad M, Kamali S (2014): Influence of splenectomy on immunoglobulins and complement components in major thalassemia. Caspian J Intern Med ; 6(1): 30-33.
Khuhapinant A, Bunyaratvej A, Tatsumi N, Pribwai M and Fucharoen S (1994): Number and maturation of reticulocytes in various genotypes of thalassemia as assessed by flow cytometry. Acta Haematologica, vol. 91, no. 3, pp. 119125.
Neal J, Weinreb, Barry E and Rosenbloom (2013): Splenomegaly, hypersplenism, and hereditary disorders with splenomegaly. Open Journal of Genetics 3: 24-43.
Ruchaneekorn W. Kalpravidh, Thongchai Tangjaidee, Suneerat Hatairaktham, Ratiya Charoensakdi, Narumol Panichkul, Noppadol Siritanaratkul and Suthat Fucharoen (2013): Glutathione Redox System in -Thalassemia/Hb E Patients. The Scientific World Journal Volume 2013, Article ID 543973, 7 pages.
Shodikin M A, Suwarniaty R and Nugroho S (2016): Correlation between Serum ferritin and Cardiac troponin I in major beta thalassemia Children, the journal of tropical life science, VOL. 6, NO. 1, pp. 10-14.
Tolba M R, Soliman N A, El- kamah G Y and EL-shehaby A I (2015): Oxidative Stress Parameters in Beta-Thalassemia. International Journal of Life Sciences Research, Vol. 3, Issue 4.
Vento S, Cainelli F, and Cesario F (2006): Infections and thalassemia. Lancet Infectious Diseases, vol. 6, no. 4, pp. 226–233.